This repository has been archived by the owner on Sep 20, 2024. It is now read-only.
UC 1a. Develop a more accurate pipeline to detect de novo mutations in family trios by utilizing the consistent calls #2
Labels
SYS INTEROP
System interoperability use case
Interop Contact: Allison Heath
Active in 2021: [Inactive]
Researchers: Bruce Gelb (Mount Sinai), i)
**Platforms" NHLBI BioData Catalyst + Kids First DRC
Analysis Question: The Pediatric Cardiovascular Genetics Consortium (PCGC) is committed to defining the molecular mechanisms for Congenital Heart Disease. They have developed a novel method to identify de novo mutations in clinical probands by post-processing the family genotypes posited by the GATK whole-genome sequencing (WGS) pipeline.
This method has a precision rate of 95% for de novo SNVs as well as short INDELs (validated by Sanger sequencing of the putative calls). Seven Bridges Genomics, Inc. (SBG) has recently described Pan-genome Graph References for improved WGS analyses and presented the use of personalized genome graphs for more consistent variant calling in family trios (ASHG 2019).
This collaboration aims to develop a more accurate pipeline to detect de novo mutations in family trios by utilizing the consistent calls and other graph-related information produced by the SBG graph tools in the PCGC pipeline.
Analysis Plan:
(ideally) Through a single sign on event, authenticate user and authorize appropriate access through RAS integration
Provide new PCGC callset to approved researchers for analysis and further community validation / potential method refinement
If improvement, run across Kids First and TOPMed studies of interest to provide callsets to the community
The text was updated successfully, but these errors were encountered: